Keyphrases
Interleukin-6
100%
Plasma Concentration
100%
COVID-19
100%
Multisystem Inflammatory Syndrome in children (MIS-C)
100%
Pediatric Sepsis
100%
Sepsis
50%
Shock
28%
Clinical Outcomes
14%
C-reactive Protein
14%
Septic Shock
14%
Critically Ill children
14%
Children's Group
14%
Interleukin-6 Levels
14%
Procalcitonin
14%
Interleukin-6 Inhibitors
14%
No Significant Difference
7%
Intensive Care Unit
7%
Drug Use
7%
18 Years Old
7%
Mechanical Ventilation
7%
Retrospective Cohort Study
7%
Septic Patients
7%
Subgroup Analysis
7%
Immunomodulation
7%
Intensive Care
7%
Dysregulated Immune Response
7%
Pathobiology
7%
Critically Ill
7%
Immunodeficiency
7%
Inflammatory Biomarkers
7%
SARS-CoV-2 Infection
7%
Immunosuppressive Therapy
7%
CDC Criteria
7%
Child Patients
7%
Post-viral
7%
Surviving Sepsis Campaign
7%
Individual Patient Data
7%
Off-label Use
7%
Medicine and Dentistry
Sepsis
100%
Pediatrics
100%
Serositis
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Interleukin 6
100%
Shock (Circulatory)
28%
Septic Shock
14%
C Reactive Protein
14%
Procalcitonin
14%
Immune Response
7%
Infection
7%
Artificial Respiration
7%
Biological Marker
7%
Immunosuppressive Treatment
7%
Intensive Care Unit
7%
Intensive Care
7%
Retrospective Cohort Study
7%
Immune Deficiency
7%
Subgroup Analysis
7%
Vasoactive Agent
7%
6 Diazo 5 Oxonorleucine
7%
Patient-Data
7%
Immunomodulation
7%
Drug Use
7%
Off-Label Use
7%
Nursing and Health Professions
Blood Level
100%
Inflammation
100%
Sepsis
100%
Severe Acute Respiratory Syndrome
100%
Interleukin 6
100%
Clinical Outcome
14%
C Reactive Protein
14%
Procalcitonin
14%
Septic Shock
14%
Intensive Care Unit
7%
Cohort Analysis
7%
Intensive Care
7%
Immunosuppressive Treatment
7%
Infection
7%
Immune Deficiency
7%
Artificial Respiration
7%
Biological Marker
7%
6 Diazo 5 Oxonorleucine
7%
Vasoactive Agent
7%
Off-Label Use
7%
Drug Use
7%
Patient Coding
7%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Sepsis
100%
Interleukin 6
100%
SARS Coronavirus
100%
C Reactive Protein
14%
Septic Shock
14%
Procalcitonin
14%
Infection
7%
Immunosuppressive Agent
7%
Biological Marker
7%
Cohort Study
7%
Immune Deficiency
7%
Immunomodulation
7%
Off-Label Use
7%
Vasoactive Agent
7%
6 Diazo 5 Oxonorleucine
7%
Immunology and Microbiology
Interleukin 6
100%
Blood Level
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Blood Plasma
15%
C-Reactive Protein
15%
Procalcitonin
15%
Immune Response
7%
Immunomodulation
7%
Immunodeficiency
7%
Patient Coding
7%
Immunosuppressive Therapy
7%